首页> 外国专利> Composition for stabilizing corneal tissue during or after corneal correction lens wearing

Composition for stabilizing corneal tissue during or after corneal correction lens wearing

机译:用于在角膜矫正眼镜佩戴期间或之后稳定角膜组织的组合物

摘要

Two types of compositions having an eye-drop delivery system are used during or after an orthokeratology procedure to prevent or retard relaxation of corneal tissue back to the original anterior curvature of the cornea. Each composition functions independently from the others and is a different approach of preparing a stabilizing agent. The first composition is directed to a biologically compatible composition comprising fibril associated collogens with interrupted triple helices (FACITs) and/or small leucine-rich repeat proteoglycans (SLRPs). The fibril associated collogen family includes various types of collogens, such as type VI, type XX, type XII, and type XIV. The small leucine-rich repeat proteoglycans family includes decorin, keratocan, biglycan, epiphycan, lumican, mimecan, and fibromodulin. The second composition includes the enzyme found as a normal component of tissues, plasma, or epidermis, such as transglutaminase.
机译:在角膜塑形术过程中或之后使用两种具有滴眼剂递送系统的组合物,以防止或阻止角膜组织松弛回到角膜的原始前曲度。每种组合物都彼此独立地起作用,并且是制备稳定剂的不同方法。第一组合物涉及生物相容性组合物,其包含具有中断的三重螺旋(FACIT)和/或富含亮氨酸的小重复蛋白聚糖(SLRP)的原纤维相关胶原蛋白。纤维相关的胶原蛋白家族包括各种类型的胶原蛋白,例如VI型,XX型,XII型和XIV型。富含亮氨酸的重复蛋白聚糖小家族包括:核心蛋白聚糖,角蛋白聚糖,双糖链蛋白聚糖,附生菌素,卢米肯,米美肯和纤维调节蛋白。第二种组合物包括发现为组织,血浆或表皮的正常成分的酶,例如转谷氨酰胺酶。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号